Related Experiment Video

Updated: Apr 24, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

2.5K

Epigenetic engineering and the art of epigenetic manipulation

Luca Magnani

    Genome Biology
    |September 3, 2014
    PubMed

    Abstract:

    A report on the Epigenetic Engineering Meeting hosted by the Barts Institute of Cancer, held in London, UK, May 7, 2014.

    More Related Videos

    Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
    10:28

    Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

    Published on: September 20, 2018

    6.1K
    Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
    09:56

    Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins

    Published on: October 31, 2025

    666

    Related Experiment Videos

    Last Updated: Apr 24, 2026

    In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
    10:44

    In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

    Published on: May 5, 2023

    2.5K
    Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
    10:28

    Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

    Published on: September 20, 2018

    6.1K
    Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
    09:56

    Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins

    Published on: October 31, 2025

    666

    Related Concept Videos

    Epigenetic Regulation01:37

    Epigenetic Regulation

    3.3K
    Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
    X-chromosome...
    3.3K
    Epigenetic Regulation01:46

    Epigenetic Regulation

    28.6K
    Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
    28.6K
    Epigenetic Regulation01:46

    Epigenetic Regulation

    24.0K
    24.0K
    What is Genetic Engineering?00:49

    What is Genetic Engineering?

    70.3K
    Overview
    70.3K
    Recombinant DNA01:09

    Recombinant DNA

    17.4K
    17.4K
    Chromatin Modification in iPS Cells01:32

    Chromatin Modification in iPS Cells

    1.5K
    Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
    Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
    1.5K

    Articles linked to this work by shared authors, journal, and citation graph.

    Temporal Clinical Ultrasound Asynchrony in Psoriatic Arthritis Enthesitis: Implications for Personalized Monitoring.

    Journal of personalized medicine·2026

    Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

    RMD open·2026

    GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

    Clinical epigenetics·2026

    Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review.

    BMJ supportive & palliative care·2026

    Age and onset timing of Raynaud's phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR).

    Therapeutic advances in musculoskeletal disease·2026

    Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry.

    Arthritis care & research·2025

    Determinants of mutation susceptibility along the genome are largely invariant across human tissues.

    Genome biology·2026

    Benchmarking cell-type deconvolution in cross-platform transcriptomic data.

    Genome biology·2026

    Interpretable distillation reveals that deep learning splicing models suffer from pervasive confounders and blind spots.

    Genome biology·2026

    Ancient genomics study reveals low HLA diversity in eastern hunter-gatherers.

    Genome biology·2026

    Comprehensive benchmarking of RNA velocity methods across single-cell datasets.

    Genome biology·2026

    The hidden sources of spurious fusion transcripts in plants.

    Genome biology·2026

    Integrated Genetic Risk Stratification Identifies High Adenoma Detection Rates at Colonoscopy in a Real-World US Health System.

    Gastro hep advances·2026

    Immune Dysregulation and Viral Persistence in HPV-HIV Coinfection: Oncogenic and Clinical Implications.

    HIV/AIDS (Auckland, N.Z.)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us